Label: SENNA-PLUS- sennosides and docusate sodium tablet

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated December 11, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Docusate Sodium 50 mg
    Sennosides 8.6 mg

  • Purpose

    Stool softener

    Laxative

  • Uses

    •
    relieves occasional constipation (irregularity)
    •
    this product generally produces a bowel movement in 6 to 12 hours
  • Warnings

    Do not use for more than one week unless directed by a doctor

    Ask a doctor before use if you

    •
    have abdominal pain, nausea or vomiting
    •
    are taking mineral oil
    •
    have noticed a sudden change in bowel habits that lasts over two weeks

    Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.
    These may indicate a serious condition.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • do not exceed 8 tablets in 24 hours

    Age
    		Starting Dose
    		Maximum Dose

    adults and children 12 years of age and older

    2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor

    4 tablets in the morning and 4 tablets at bedtime

    children under 12 years

    ask a doctor

  • Other information

    •
    each tablet contains: calcium 20 mg, sodium 3 mg
    •
    store at controlled room temperature
    Tamper Evident: Do not use if imprinted seal under cap is missing or broken.
    •
    product of India

    Repackaged By: Preferred Pharmaceuticals Inc.

  • Inactive ingredients

    cellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6 lake, hypromellose, magnesium stearate, PEG, silica, talc, titanium dioxide.

  • Package Label

    Senna Plus Tablets
  • INGREDIENTS AND APPEARANCE
    SENNA-PLUS 
    sennosides and docusate sodium tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-8780(NDC:57896-555)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    Inactive Ingredients
    Ingredient NameStrength
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    TALC (UNII: 7SEV7J4R1U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    ColororangeScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code PSD22
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68788-8780-330 in 1 BOTTLE; Type 0: Not a Combination Product12/11/2024
    2NDC:68788-8780-1100 in 1 BOTTLE; Type 0: Not a Combination Product12/11/2024
    3NDC:68788-8780-8120 in 1 BOTTLE; Type 0: Not a Combination Product12/11/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)12/11/2024
    Labeler - Preferred Pharmaceuticals Inc. (791119022)
    Registrant - Preferred Pharmaceuticals Inc. (791119022)
    Establishment
    NameAddressID/FEIBusiness Operations
    Preferred Pharmaceuticals Inc.791119022REPACK(68788-8780)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!